Circadian uses of melatonin in humans

Alfred Lewy, Jonathan Emens, Angela Jackman, Krista Yuhas

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Melatonin in humans can be an independent or dependent variable. Measurement of endogenous melatonin levels under dim-light conditions, particularly the dim-light melatonin onset (DLMO), has received increasing attention among researchers, and for clinicians it may soon become a convenient test that can be done at home using saliva collections in the evening, without interfering with sleep. Melatonin, even at low physiological doses, can cause advances (shifts to an earlier time) or delays (shifts to a later time) depending on when it is administered on its phase-response curve (in most sighted people, these times are approximately in the p.m. and in the a.m., respectively). Although both bright light and melatonin can be used separately or together in the treatment of circadian phase disorders in sighted people - such as advanced and delayed sleep phase syndromes, jet lag, shift-work maladaptation, and winter depression (seasonal affective disorder, or SAD) - melatonin is the treatment of choice in totally blind people. These people provide a unique opportunity to study the human circadian system without the overwhelming effects of ocularly mediated light, thus permitting us to establish that all blind free-runners (BFRs) studied under high resolution appear to have phase-advancing and phase-delaying responses to as yet unidentified zeitgebers (time givers) that are usually too weak to result in entrainment.

Original languageEnglish (US)
Pages (from-to)403-412
Number of pages10
JournalChronobiology International
Volume23
Issue number1-2
DOIs
StatePublished - 2006

Fingerprint

melatonin
Melatonin
Circadian Rhythm Sleep Disorders
Light
sleep
Seasonal Affective Disorder
work schedules
saliva
Saliva
Sleep
researchers
Research Personnel
Depression
winter
Therapeutics
dosage
testing

Keywords

  • Blind people
  • Circadian rhythms
  • Melatonin
  • Seasonal affective disorder (SAD)
  • Winter depression

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Physiology
  • Physiology (medical)

Cite this

Circadian uses of melatonin in humans. / Lewy, Alfred; Emens, Jonathan; Jackman, Angela; Yuhas, Krista.

In: Chronobiology International, Vol. 23, No. 1-2, 2006, p. 403-412.

Research output: Contribution to journalArticle

Lewy, Alfred ; Emens, Jonathan ; Jackman, Angela ; Yuhas, Krista. / Circadian uses of melatonin in humans. In: Chronobiology International. 2006 ; Vol. 23, No. 1-2. pp. 403-412.
@article{e0388025f2e34c4b9d4c93d5ae0e4b4e,
title = "Circadian uses of melatonin in humans",
abstract = "Melatonin in humans can be an independent or dependent variable. Measurement of endogenous melatonin levels under dim-light conditions, particularly the dim-light melatonin onset (DLMO), has received increasing attention among researchers, and for clinicians it may soon become a convenient test that can be done at home using saliva collections in the evening, without interfering with sleep. Melatonin, even at low physiological doses, can cause advances (shifts to an earlier time) or delays (shifts to a later time) depending on when it is administered on its phase-response curve (in most sighted people, these times are approximately in the p.m. and in the a.m., respectively). Although both bright light and melatonin can be used separately or together in the treatment of circadian phase disorders in sighted people - such as advanced and delayed sleep phase syndromes, jet lag, shift-work maladaptation, and winter depression (seasonal affective disorder, or SAD) - melatonin is the treatment of choice in totally blind people. These people provide a unique opportunity to study the human circadian system without the overwhelming effects of ocularly mediated light, thus permitting us to establish that all blind free-runners (BFRs) studied under high resolution appear to have phase-advancing and phase-delaying responses to as yet unidentified zeitgebers (time givers) that are usually too weak to result in entrainment.",
keywords = "Blind people, Circadian rhythms, Melatonin, Seasonal affective disorder (SAD), Winter depression",
author = "Alfred Lewy and Jonathan Emens and Angela Jackman and Krista Yuhas",
year = "2006",
doi = "10.1080/07420520500545862",
language = "English (US)",
volume = "23",
pages = "403--412",
journal = "Chronobiology International",
issn = "0742-0528",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Circadian uses of melatonin in humans

AU - Lewy, Alfred

AU - Emens, Jonathan

AU - Jackman, Angela

AU - Yuhas, Krista

PY - 2006

Y1 - 2006

N2 - Melatonin in humans can be an independent or dependent variable. Measurement of endogenous melatonin levels under dim-light conditions, particularly the dim-light melatonin onset (DLMO), has received increasing attention among researchers, and for clinicians it may soon become a convenient test that can be done at home using saliva collections in the evening, without interfering with sleep. Melatonin, even at low physiological doses, can cause advances (shifts to an earlier time) or delays (shifts to a later time) depending on when it is administered on its phase-response curve (in most sighted people, these times are approximately in the p.m. and in the a.m., respectively). Although both bright light and melatonin can be used separately or together in the treatment of circadian phase disorders in sighted people - such as advanced and delayed sleep phase syndromes, jet lag, shift-work maladaptation, and winter depression (seasonal affective disorder, or SAD) - melatonin is the treatment of choice in totally blind people. These people provide a unique opportunity to study the human circadian system without the overwhelming effects of ocularly mediated light, thus permitting us to establish that all blind free-runners (BFRs) studied under high resolution appear to have phase-advancing and phase-delaying responses to as yet unidentified zeitgebers (time givers) that are usually too weak to result in entrainment.

AB - Melatonin in humans can be an independent or dependent variable. Measurement of endogenous melatonin levels under dim-light conditions, particularly the dim-light melatonin onset (DLMO), has received increasing attention among researchers, and for clinicians it may soon become a convenient test that can be done at home using saliva collections in the evening, without interfering with sleep. Melatonin, even at low physiological doses, can cause advances (shifts to an earlier time) or delays (shifts to a later time) depending on when it is administered on its phase-response curve (in most sighted people, these times are approximately in the p.m. and in the a.m., respectively). Although both bright light and melatonin can be used separately or together in the treatment of circadian phase disorders in sighted people - such as advanced and delayed sleep phase syndromes, jet lag, shift-work maladaptation, and winter depression (seasonal affective disorder, or SAD) - melatonin is the treatment of choice in totally blind people. These people provide a unique opportunity to study the human circadian system without the overwhelming effects of ocularly mediated light, thus permitting us to establish that all blind free-runners (BFRs) studied under high resolution appear to have phase-advancing and phase-delaying responses to as yet unidentified zeitgebers (time givers) that are usually too weak to result in entrainment.

KW - Blind people

KW - Circadian rhythms

KW - Melatonin

KW - Seasonal affective disorder (SAD)

KW - Winter depression

UR - http://www.scopus.com/inward/record.url?scp=33646703126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646703126&partnerID=8YFLogxK

U2 - 10.1080/07420520500545862

DO - 10.1080/07420520500545862

M3 - Article

C2 - 16687313

AN - SCOPUS:33646703126

VL - 23

SP - 403

EP - 412

JO - Chronobiology International

JF - Chronobiology International

SN - 0742-0528

IS - 1-2

ER -